BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29359963)

  • 21. miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer.
    Zhang J; Zhu Z; Sheng J; Yu Z; Yao B; Huang K; Zhou L; Qiu Z; Huang C
    Oncotarget; 2017 May; 8(21):34867-34883. PubMed ID: 28432273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
    Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-152-5p inhibits proliferation and migration and promotes apoptosis by regulating expression of Smad3 in human keloid fibroblasts.
    Pang Q; Wang Y; Xu M; Xu J; Xu S; Shen Y; Xu J; Lei R
    BMB Rep; 2019 Mar; 52(3):202-207. PubMed ID: 30638178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B.
    Cheng CM; Shiah SG; Huang CC; Hsiao JR; Chang JY
    J Pathol; 2016 Sep; 240(1):38-49. PubMed ID: 27235675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
    Wu H; Huang M; Lu M; Zhu W; Shu Y; Cao P; Liu P
    Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
    Ge X; Liu X; Lin F; Li P; Liu K; Geng R; Dai C; Lin Y; Tang W; Wu Z; Chang J; Lu J; Li J
    Oncotarget; 2016 Apr; 7(17):24466-82. PubMed ID: 27016414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-665 inhibits epithelial-to-mesenchymal transition in bladder cancer via the SMAD3/SNAIL axis.
    Wang W; Ying Y; Xie H; Li J; Ma X; He L; Xu M; Chen S; Shen H; Zheng X; Liu B; Wang X; Xie L
    Cell Cycle; 2021 Jul; 20(13):1242-1252. PubMed ID: 34196584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic Role of MiR-140-5p for the Treatment of Non-small Cell Lung Cancer.
    Flamini V; Jiang WG; Cui Y
    Anticancer Res; 2017 Aug; 37(8):4319-4327. PubMed ID: 28739724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.
    Zhou X; Jin W; Jia H; Yan J; Zhang G
    J Exp Clin Cancer Res; 2015 Mar; 34(1):28. PubMed ID: 25888377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer.
    Lacerda JZ; Ferreira LC; Lopes BC; Aristizábal-Pachón AF; Bajgelman MC; Borin TF; Zuccari DAPC
    Microrna; 2019; 8(3):237-247. PubMed ID: 30806335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
    Deng Y; Huang Z; Xu Y; Jin J; Zhuo W; Zhang C; Zhang X; Shen M; Yan X; Wang L; Wang X; Kang Y; Si J; Zhou T
    Cancer Lett; 2014 Jan; 342(1):27-35. PubMed ID: 23981575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation.
    Zhu M; Wang M; Yang F; Tian Y; Cai J; Yang H; Fu H; Mao F; Zhu W; Qian H; Xu W
    Oncotarget; 2016 Mar; 7(13):16567-80. PubMed ID: 26934326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
    Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
    Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
    Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L
    Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma.
    Zhang X; Zhang Y; Yang J; Li S; Chen J
    Cancer Gene Ther; 2015 Oct; 22(10):475-80. PubMed ID: 26384136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1.
    Tong Z; Liu N; Lin L; Guo X; Yang D; Zhang Q
    Biomed Pharmacother; 2015 Oct; 75():129-36. PubMed ID: 26297542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer.
    Huang H; Sun P; Lei Z; Li M; Wang Y; Zhang HT; Liu J
    Tumour Biol; 2015 Jun; 36(6):4123-31. PubMed ID: 25578496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1.
    Lee KH; Lin FC; Hsu TI; Lin JT; Guo JH; Tsai CH; Lee YC; Lee YC; Chen CL; Hsiao M; Lu PJ
    Biochim Biophys Acta; 2014 Sep; 1843(9):2055-66. PubMed ID: 24915000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Jin H; Qiao F; Wang Y; Xu Y; Shang Y
    Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.